Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma

BACKGROUND: In a recently published retrospective case series, Temozolomide was found active as second line approach in advanced ACC patients. The disease control rate obtained, however, was short-lived. We report here an ACC patient with extensive metastatic disease who obtained a remarkable long l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Cosentini, Deborah, Turla, Antonella, Carminati, Ornella, Grisanti, Salvatore, Ferrari, Vittorio Domenico, Laganà, Marta, Rosti, Giovanni, Sigala, Sandra, Berruti, Alfredo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8101262/
https://ncbi.nlm.nih.gov/pubmed/33967965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.674039
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak